After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...

The FDA has officially placed two of Intellia’s Phase III studies under clinical hold after the biotech reported earlier this ...

Intellia paused both trials after receiving a report of grade 4 liver enzymes and increased total bilirubin in a patient in ...

Intellia earlier this year reported a similar grade 4 liver enzyme elevation associated with the gene therapy nexiguran ...

The humble henna plant, famed for its vibrant dye, could hold the key to healing scarred livers. In a new study, researchers have found that its active compound, lawsone, may stop and even reverse ...

Intellia Therapeutics has temporarily stopped dosing and patient screening in two late-stage studies of its gene therapy after a participant developed serious liver injury, the company said on Monday, ...

Once considered an urban disease, non-alcoholic fatty liver is now spreading across rural India as well, fuelled by changing diets, alcohol consumption and poor sleep. Firstpost explores expert ...

Emerging research shows certain foods can protect liver function, reduce inflammation and even prevent fat accumulation in ...

Henna dye may do more than colour hair. A Japanese study found that a natural compound in the henna plant could help reverse ...

Antidepressants show clinically significant and highly heterogeneous effects on cardiometabolic parameters, weight, and blood ...